ARHGAP28 Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9P2N2 |
---|---|
Clone Names | 110811015 |
Other Names | Rho GTPase-activating protein 28, Rho-type GTPase-activating protein 28, ARHGAP28, KIAA1314 |
---|---|
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | ARHGAP28 |
---|---|
Synonyms | KIAA1314 |
Function | GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. |
Tissue Location | Expressed in testis. Expressed at moderate level in kidney and ovary, and weakly expressed in spleen and skeletal muscle |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state (By similarity).
References
Nusbaum, C., et al. Nature 437(7058):551-555(2005)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.